European Society of Toxicologic Pathology (ESTP)
    European Society of Toxicologic Pathology
Welcome to the Home page of the ESTP !
 

19th European Congress of Toxicologic Pathology


The 19th European Congress of Toxicologic Pathology will be held in Maastricht, The Netherlands, and will take place from 13th – 16th of September 2022.

The ESTP topic will be: "Think Female: Toxicologic Pathology of the Female Reproductive System". The congress will focus on the female reproductive system and will cover the normal and pathologic female reproductive system and new techniques, models and challenges in clinical development and risk assessment of hormonally active/endocrine-related compounds. There will be plenary lectures, oral presentations of original scientific work, interactive case presentations, a half-day IATP session, a poster session and of course plenty of opportunity for interactions both formally and informally with colleagues and friends.

The link to the official congress website will come soon.

   

(Photo: Maastricht: AdobeStock)

Please mark your calendar


Further ESTP news and announcements:

Classic Examples in Toxicologic Pathology XXIX
This seminar is offered by the ESTP and the Hannover Graduate School for Veterinary Pathobiology, Neuroinfectiology, and Translational Medicine online on March 10 and 11, 2022. On-line registration is now available. Click here for more information.
[30-Nov-2021 ]


ESTP newsletter 2021 (3)
The third ESTP newsletter 2021 containing a President's column referring to our three new honorary members and a short response by two of them, announcements of the Clinical Pathology and Biomarkers committee and ESTP Mission and Vision task force, a call for "mystery case" presentations for 2022 in Maastricht and looking back to the virtual 18th European Congress of Toxicologic Pathology at the 4th Cutting Edge Pathology Congress and ESTP publication award is now available here. Previous newsletters are accessible in the repository.
[24-Nov-2021 ]


Guess What!
Case #28

Interesting cases from the field of toxicologic pathology are presented each year in this interactive ESTP section. The new case #28 is now available.

[25-Feb-2021 ]


17th European Congress of Toxicologic Pathology
We are looking back to the very successful Congress 2019, which took place in Cologne, Germany. Click for more details.
[11-Oct-2019 ]



[30-Aug-2019 ]

 
INHAND Non-human Primate and INHAND Rabbit now published online!
Dog: Journal of Toxicologic Pathology 2021, Vol. 34(3 Suppl) 1S–182S
Rabbit: Journal of Toxicologic Pathology 2021, Vol. 34(3 Suppl) 183S–292S
[27-Oct-2021 ]


Call for Papers for a Special Issue of Toxicologic Pathology
Toxicologic Pathology is pleased to announce the publication of a special issue in 2022 focusing on The pathology of laboratory nonhuman primates; a review of species, sub-strain, and mortality-related responses. Please read the Call for Papers.
[18-Mar-2021 ]


Revision of Standardized Nomenclature
goRENI - the global open RENI system - is the standard reference for nomenclature and diagnostic criteria in toxicologic pathology and at the same time the Internet discussion platform for the global initiative "INHAND" - the International Harmonization of Nomenclature and Diagnostic criteria. Visit www.goRENI.org for more details. ESTP members have free access to the nomenclature, diagnostic criteria, images, and much more!
The following diagnosis has been added through change control: Tumor, granular cell, benign – Soft tissue. Templates for change control are available on goRENI and here.
[24-Nov-2020 ]


Updates to the Web site
For those visiting the Web site on a regular basis the Updates functionality is always available to find recent changes more easily.
[04-Aug-2008 ]


The ESTP Committee for Scientific Standards (CSS) prepared a response to the recently published FDA guidance "Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers, Guidance for Industry". This draft guidance was published in the Federal register August 1st, 2019 for public comment and originated from the FDA Office of Study Integrity and Surveillance (OSIS). Herewith, we would also like to thank you those members and organizations, which have shared their comments and responses regarding this Draft guidance with us.
The finalized ESTP CSS comments have been endorsed by the ESTP Executive Committee, and were submitted electronically and by UPS to the FDA October 18th, 2019. The committee had agreed with FDA representatives an extension of the official comment period.
If you have any questions or comments, please reach out to the working group chair, Annette Romeike (annette.romeike@covance.com).
Annette Romeike, ESTP Chair of Committee for Scientific Standards, on behalf of the ESTP CSS – Sibylle Groeters, Laetita Elies, Erio Barale, Eveline de Rijk, Katrin Gutberlet, Flavia Pasello
[18-Nov-2019 ]